menu search

Should you buy eli lilly stock now?

Eli Lilly announced the successful results of a phase 3 trial with donanemab, an experimental treatment...

May 4, 2023, 5:13 am

Microsoft doubles down on ai with new bing features

Microsoft is embarking on the next phase of Bing's expansion. And — no surprise — it heavily revolv...

May 4, 2023, 3:00 am

Attack on kremlin risks escalation of ukraine war

A pair of drones attacked Putin's residence at the Kremlin early today and though both were shot down, they may herald a new ...

May 3, 2023, 4:24 pm

Immunogen stock price doubles after ovarian cancer candidate elahere aces phase 3 study

ImmunoGen Inc stock more than doubled after the company shared positive topline data from the phase 3 c...

May 3, 2023, 12:36 pm

Cingulate announces successful transfer of ctx-1301 (dexmethylphenidate) proprietary ptr™ manufacturing processes to societal cdmo

Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for ...

May 3, 2023, 10:45 am

Why is immunogen (imgn) stock up 125% today?

ImmunoGen (NASDAQ: IMGN ) stock is rising higher on Wednesday after the company released results from a phase ...

May 3, 2023, 10:04 am

Eli lilly's alzheimer's drug slowed cognitive decline in phase 3 study

Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's Alzheimer's treatment donanemab, which slowed disease progression in the ...

May 3, 2023, 9:56 am

Adobe's $20b figma acquisition falls on uk antitrust radar

The U.K.'s competition authority is adding Adobe's proposed $20 billion bid for digital design rival Figma to its ever-growing to-do list. The Competi...

May 3, 2023, 9:55 am

Eli lilly stock jumps on positive alzheimer's drug phase 3 trial data

The company says a phase 3 study shows that donanemab 'significantly slowed cognitive and functional de...

May 3, 2023, 6:34 am

Eli lilly stock jumps 4% premarket on news of positive results in late-stage trial of alzheimer's disease treatment

Eli Lilly & Co.'s stock LLY jumped 4% premarket Wednesday, after the company announced positive data from a late-stage trial of its Alzheimer's diseas...

May 3, 2023, 6:14 am

2 explosive stocks to buy without hesitation in 2023 and hold for at least a decade

An advertising giant and a fintech disruptor each may present compelling buy opportunities for long-term investors. Pinterest is capitalizing on mobil...

May 3, 2023, 5:45 am

Is it time to buy the s&p 500's 3 worst-performing april stocks?

Drugmaker Catalent saw production challenges a company of its caliber shouldn't be facing. Enphase Ener...

May 3, 2023, 5:31 am

Prophase labs, inc. (prph) surges 8.5%: is this an indication of further gains?

Prophase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The late...

May 3, 2023, 5:20 am

Tscan therapeutics announces upcoming trial in progress poster presentation at the american society of gene and cell therapy 26th annual meeting

Company to host a virtual event to discuss highlights from its phase 1 umbrella trial of TSC-100 and TS...

May 2, 2023, 8:42 pm

Cellectis announces oral presentation on ameli-01 and poster presentation on multiplex engineering for superior generation of car t-cells at the american society of gene and cell therapy (asgct) annua

NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology co...

May 2, 2023, 8:35 pm

2seventy bio to present new preclinical and clinical data from broad portfolio of investigational cell therapies at the asgct 26th annual meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced the presentation...

May 2, 2023, 4:37 pm

Travere therapeutics stock slides 35% after announcing disappointing results from 2-year trial of kidney drug

Travere Therapeutics Inc.'s stock TVTX tumbled 35% Tuesday, after the company said data from a two-year study of a kidney drug failed to show a statis...

May 2, 2023, 12:50 pm

Sidus space signs mou with lulav space for guidance navigation and control solution for lunar missions

Sidus Space Inc (NASDAQ:SIDU) said it will be providing a complete guidance navigation and control solution (GN&C) for lunar satellite and lunar land...

May 2, 2023, 11:33 am

Astrazeneca fda vote worth potentially us$500mln annual peak sales

AstraZeneca PLC (LSE:AZN) forecasts for its major Lynparza drug are expected to be trimmed following an advisory vote against full approval in the US...

May 2, 2023, 10:45 am


Search within

Pages Search Results: